相似文献
1
Tissue factor and thrombosis: The clot starts here.
Thromb Haemost. 2010 Sep;104(3):432-9. doi: 10.1160/TH09-11-0771. Epub 2010 Jun 10.
2
Human pancreatic tumors grown in mice release tissue factor-positive microvesicles that increase venous clot size.
J Thromb Haemost. 2017 Nov;15(11):2208-2217. doi: 10.1111/jth.13809. Epub 2017 Sep 20.
3
Ticagrelor, but not clopidogrel, reduces arterial thrombosis via endothelial tissue factor suppression.
Cardiovasc Res. 2017 Jan;113(1):61-69. doi: 10.1093/cvr/cvw233. Epub 2016 Nov 15.
4
Tissue Factor: An Essential Mediator of Hemostasis and Trigger of Thrombosis.
Arterioscler Thromb Vasc Biol. 2018 Apr;38(4):709-725. doi: 10.1161/ATVBAHA.117.309846. Epub 2018 Feb 8.
5
Prostaglandin-endoperoxide synthase-2 deletion affects the natural trafficking of Annexin A2 in monocytes and favours venous thrombosis in mice.
Thromb Haemost. 2017 Jul 26;117(8):1486-1497. doi: 10.1160/TH16-12-0968. Epub 2017 May 24.
6
Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2149-57. doi: 10.1161/ATVBAHA.112.253989. Epub 2012 Jul 5.
7
Clinical Significance of Tissue Factor-Exposing Microparticles in Arterial and Venous Thrombosis.
Semin Thromb Hemost. 2015 Oct;41(7):718-27. doi: 10.1055/s-0035-1556047. Epub 2015 Sep 26.
8
Evaluation of AR-H067637, the active metabolite of the new direct thrombin inhibitor AZD0837, in models of venous and arterial thrombosis and bleeding in anaesthetised rats.
Thromb Haemost. 2010 Dec;104(6):1242-9. doi: 10.1160/TH09-10-0744. Epub 2010 Aug 30.
9
BMS-593214, an active site-directed factor VIIa inhibitor: enzyme kinetics, antithrombotic and antihaemostatic studies.
Thromb Haemost. 2010 Aug;104(2):261-9. doi: 10.1160/TH10-01-0025. Epub 2010 Jun 29.
10
Possible involvement of cytokines in diffuse intravascular coagulation and thrombosis.
Baillieres Best Pract Res Clin Haematol. 1999 Sep;12(3):343-59. doi: 10.1053/beha.1999.0029.
引用本文的文献
1
The Construction of a Molecular Model for the Ternary Protein Complex of Intrinsic Coagulation Pathway Factors Provides Novel Insights for the Pathogenesis of Cross-Reactive Material Positive Coagulation Factor Mutations.
Int J Mol Sci. 2025 May 28;26(11):5191. doi: 10.3390/ijms26115191.
2
Cutting edge of immune response and immunosuppressants in allogeneic and xenogeneic islet transplantation.
Front Immunol. 2024 Sep 13;15:1455691. doi: 10.3389/fimmu.2024.1455691. eCollection 2024.
3
Differential roles of eosinophils in cardiovascular disease.
Nat Rev Cardiol. 2025 Mar;22(3):165-182. doi: 10.1038/s41569-024-01071-5. Epub 2024 Sep 16.
4
Beyond Anticoagulation: A Comprehensive Review of Non-Vitamin K Oral Anticoagulants (NOACs) in Inflammation and Protease-Activated Receptor Signaling.
Int J Mol Sci. 2024 Aug 10;25(16):8727. doi: 10.3390/ijms25168727.
5
Development and Validation of an ICU-Venous Thromboembolism Prediction Model Using Machine Learning Approaches: A Multicenter Study.
Int J Gen Med. 2024 Jul 24;17:3279-3292. doi: 10.2147/IJGM.S467374. eCollection 2024.
6
The Impact of Cytokines on Coagulation Profile in COVID-19 Patients: Controlled for Socio-Demographic, Clinical, and Laboratory Parameters.
Biomedicines. 2024 Jun 10;12(6):1281. doi: 10.3390/biomedicines12061281.
7
Neurovascular Adverse Effects of Sars-Cov-2 Vaccination.
Drug Des Devel Ther. 2024 May 30;18:1891-1905. doi: 10.2147/DDDT.S464394. eCollection 2024.
8
Medical ozone alleviates acute lung injury by enhancing phagocytosis targeting NETs AMPK/SR-A1 axis.
J Biomed Res. 2024 May 25;38(6):1-16. doi: 10.7555/JBR.38.20240038.
9
Deciphering the triad of endothelial glycocalyx, von Willebrand Factor, and P-selectin in inflammation-induced coagulation.
Front Cell Dev Biol. 2024 Apr 30;12:1372355. doi: 10.3389/fcell.2024.1372355. eCollection 2024.
10
Trauma diagnostic-related target proteins and their detection techniques.
Expert Rev Mol Med. 2024 Apr 11;26:e7. doi: 10.1017/erm.2024.3.
本文引用的文献
1
Tissue factor activity of blood mononuclear cells is increased after total knee arthroplasty.
Thromb Haemost. 2009 Oct;102(4):728-34. doi: 10.1160/TH09-04-0261.
2
Levels of microparticle tissue factor activity correlate with coagulation activation in endotoxemic mice.
J Thromb Haemost. 2009 Jul;7(7):1092-8. doi: 10.1111/j.1538-7836.2009.03448.x. Epub 2009 Apr 27.
3
Inferior vena cava ligation rapidly induces tissue factor expression and venous thrombosis in rats.
Arterioscler Thromb Vasc Biol. 2009 Jun;29(6):863-9. doi: 10.1161/ATVBAHA.109.185678. Epub 2009 Mar 5.
4
Vascular smooth muscle-derived tissue factor is critical for arterial thrombosis after ferric chloride-induced injury.
Blood. 2009 Jan 15;113(3):705-13. doi: 10.1182/blood-2007-05-090944. Epub 2008 Oct 17.
5
Triggers, targets and treatments for thrombosis.
Nature. 2008 Feb 21;451(7181):914-8. doi: 10.1038/nature06797.
6
Effects of hyperglycemia and hyperinsulinemia on the tissue factor pathway of blood coagulation.
Curr Diab Rep. 2007 Jun;7(3):223-7. doi: 10.1007/s11892-007-0035-1.
7
Epidemiology and risk factors for venous thrombosis.
Semin Hematol. 2007 Apr;44(2):62-9. doi: 10.1053/j.seminhematol.2007.02.004.
8
Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer.
Thromb Haemost. 2007 Jan;97(1):119-23.
9
Eosinophils are a major intravascular location for tissue factor storage and exposure.
Blood. 2007 Feb 1;109(3):995-1002. doi: 10.1182/blood-2006-02-004945. Epub 2006 Sep 26.
10
Procoagulant microparticles: disrupting the vascular homeostasis equation?
Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2594-604. doi: 10.1161/01.ATV.0000246775.14471.26. Epub 2006 Sep 21.
Zotero 插件